Home Compare MCO vs UTHR
Stock Comparison · Single-driver result

Moody's vs United Therapeutics: Which Stock Looks Stronger in 2026?

The structural profiles are close, with United Therapeutics carrying a narrow edge on growth. Moody's still has the edge on growth, which keeps the comparison from looking entirely one-sided. On the market side, United Therapeutics is in better shape — its trend is intact while Moody's's trend has broken down. That puts structure and market broadly in agreement — United Therapeutics's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

On growth, the clearer edge sits with Moody's Corporation, while the overall score remains tighter and points the other way.

Trajectory Similarity
0.63
Moderately similar
Peer-set rank: #29
within Moody's Corporation's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The strongest overlap appears in margin consistency and revenue growth trajectory.

Similarity drivers
margin consistencyrevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MCO
Moody's Corporation
63
Peer-Score
Signal qualityHigh
vs
UTHR
United Therapeutics Corporation
66
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: MCO vs UTHR Profitability 76 79 Stability 35 51 Valuation 53 82 Growth 84 40 MCO UTHR
Gap Ranking
#1 Growth +44
#2 Valuation +29
#3 Stability +16
#4 Profitability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MCO and UTHR Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MCOUTHR Relative valuation Structural strength

Moody's Corporation looks stronger, but the price setup still looks more supportive for United Therapeutics Corporation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both profiles are strong on growth, but Moody's Corporation leads clearly.
Valuation
On valuation, the same pattern holds: both are strong, but United Therapeutics Corporation still leads clearly.
Growth — Dominant Gap
MCO
84
UTHR
40
Gap+44in favour of MCO

The current lead is backed by a stronger multi-year growth trajectory.

What keeps the gap from being one-sided

Moody's Corporation still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Growth is the clearest driver of the lead, with valuation adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the MCO vs UTHR comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how MCO and UTHR each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.